Detalles de la búsqueda
1.
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.
Br J Haematol
; 204(3): 976-987, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246862
2.
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization.
Ann Hematol
; 103(5): 1601-1611, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267561
3.
Improvement of the management of mental well-being and empathy in Chinese medical students: a randomized controlled study.
BMC Med Educ
; 21(1): 378, 2021 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246265
4.
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma.
Ann Hematol
; 99(3): 581-589, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31965271
5.
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.
Oncologist
; 24(11): e1132-e1140, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31455749
6.
Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing.
Med Sci Monit
; 25: 8269-8280, 2019 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678982
7.
Longitudinal Flow Cytometry Identified "Minimal Residual Disease" (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma.
Biol Blood Marrow Transplant
; 24(12): 2568-2574, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30142420
8.
Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.
Proc Natl Acad Sci U S A
; 111(44): 15804-9, 2014 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25331880
9.
The roles of active species in photo-decomposition of organic compounds by microwave powered electrodeless discharge lamps.
J Environ Sci (China)
; 33: 60-8, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26141878
10.
Activation of growth hormone secretagogue receptor induces time-dependent clock phase delay in mice.
Am J Physiol Endocrinol Metab
; 307(6): E515-26, 2014 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25074983
11.
Tanshinone II-A sodium sulfonate (DS-201) enhances human BKCa channel activity by selectively targeting the pore-forming α subunit.
Acta Pharmacol Sin
; 35(11): 1351-63, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345746
12.
[Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma].
Zhonghua Nei Ke Za Zhi
; 53(11): 865-72, 2014 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-25586356
13.
Β-adrenergic-stimulated L-type channel Ca²+ entry mediates hypoxic Ca²+ overload in intact heart.
J Mol Cell Cardiol
; 65: 51-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041537
14.
Proteomic studies of multiple myeloma in RPMI8226 cell line treated with bendamustine.
J BUON
; 18(4): 996-1005, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24344029
15.
Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance.
J Pers Med
; 13(3)2023 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36983594
16.
Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score.
Front Oncol
; 13: 1103687, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36741003
17.
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience.
Ann Med
; 55(2): 2289603, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104533
18.
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.
Med Oncol
; 40(4): 115, 2023 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36897488
19.
On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.
Front Oncol
; 13: 1306367, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38298443
20.
Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.
Biochem Biophys Res Commun
; 420(3): 644-50, 2012 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22450313